Day One | Monday, September 11, 2017
8:00
Registration and Continental Breakfast
9:00
Chairman’s Welcome and Opening Remarks
Sasha Zbitnoff
Associate Director, Commercial Project Management
Alkermes, Inc.
Product Launch Plan
Development and Execution
9:30
INTRODUCTORY ROUNDTABLE DISCUSSION Pre-Launch Planning for Orphan Drugs — Harness the Power of Focus
Karen Cashmere
Vice President, Strategy & Development
Variant Pharmaceuticals
10:00
Internal Best Practice for Pre-Launch Planning, Approval and Distribution
Lawrence Weiner
Senior Director, Strategic Innovation & Project Management
Biogen
10:45
Networking and Refreshment Break
11:15
Scaling Your Commercial Capabilities — Interactive Round Table Discussions
MODERATOR:
Sasha Zbitnoff
Associate Director, Commercial Project Management
Alkermes, Inc.
PANELISTS:
John Garcia
Senior Director, Launch Excellence
Alnylam Pharmaceuticals
Spotlight on IT Solutions for
Product Launch Enablement
12:00
Accelerate Early Stage Drug Development and Pre-Launch Activities with Predictive Intelligence Hubs
John Garcia
Senior Director, Launch Excellence
Alnylam Pharmaceuticals
12:45
Networking Luncheon
2:15
Navigate EHRs Use In Launch Success and Workflow Optimization
Brian Bamberger
Life Sciences Practice Lead
Point-of-Care Partners
3:00
Networking and Refreshment Break
3:30
Navigating the Essentials in Pre-Launch Market Insights
Stephen Murdock
Principal
CharlesView Solutions, LLC
4:30
Close of Day One
Networking, Wine and Cheese Reception immediately following the final session on day one
Day Two | Tuesday, September 12, 2017
7:30
Continental Breakfast
8:00
Chairman’s Review of Day One
Sasha Zbitnoff
Associate Director, Commercial Project Management
Alkermes, Inc.
Keys to Commercialization,
Marketing and Post-Launch Success
8:15
Preparing for a Global Launch — Defining a Path for New Products
Lori Peters
Senior Principal
Qpharma
9:00
The Ever-Changing Dynamics of Launch Pricing
Mike Rizzo
Principal
ClearView Healthcare Partners
9:45
Networking and Refreshment Break
10:15
New Product Pricing and Communications
Jill Charbonneau
Director Regulatory Advertising Promotions, Product Launch & Strategy
Marathon Pharmaceuticals
11:00
Optimizing the Material Review Process in the Digital Explosion Age
Jennifer Guenther
Vice President, Commercial Excellence
HighPoint Solutions
11:45
Developing a Winning Product Strategy for Launch
Ted Hoffman
Senior Director, Launch Management
Teva Pharmaceuticals
12:30
Networking Luncheon
WORKSHOP
1:30
Payer Negotiation Simulation
Incumbent Product
New Product
Payer Perspective
Workshop participants are divided into one of the three groups outlined above. The existing and new product teams develop and present formulary/rebate proposals for the payer to evaluate. Representatives from each team negotiates with the payer group. The financial implications from the manufacturer and payer’s perspective are assessed along with qualitative factors. The payer group develops and communicates their offer based on the negotiations with the teams. A panel determines which team got the most favorable outcome from the payer negotiations.
WORKSHOP LEADER:
Murray Kay
Former CFO, Solvay Pharmaceuticals &
Former Commercial Controller Specialty Products
AbbVie
3:00
Close of Conference
Day One | Monday, September 11, 2017
8:00
Registration and Continental Breakfast
9:00
Chairman’s Welcome and Opening Remarks
Sasha Zbitnoff
Associate Director, Commercial Project Management
Alkermes, Inc.
Product Launch Plan
Development and Execution
9:30
INTRODUCTORY ROUNDTABLE DISCUSSION Pre-Launch Planning for Orphan Drugs — Harness the Power of Focus
Karen Cashmere
Vice President, Strategy & Development
Variant Pharmaceuticals
10:00
Internal Best Practice for Pre-Launch Planning, Approval and Distribution
Lawrence Weiner
Senior Director, Strategic Innovation & Project Management
Biogen
10:45
Networking and Refreshment Break
11:15
Scaling Your Commercial Capabilities — Interactive Round Table Discussions
MODERATOR:
Sasha Zbitnoff
Associate Director, Commercial Project Management
Alkermes, Inc.
PANELISTS:
John Garcia
Senior Director, Launch Excellence
Alnylam Pharmaceuticals
Spotlight on IT Solutions for
Product Launch Enablement
12:00
Accelerate Early Stage Drug Development and Pre-Launch Activities with Predictive Intelligence Hubs
John Garcia
Senior Director, Launch Excellence
Alnylam Pharmaceuticals
12:45
Networking Luncheon
2:15
Navigate EHRs Use In Launch Success and Workflow Optimization
Brian Bamberger
Life Sciences Practice Lead
Point-of-Care Partners
3:00
Networking and Refreshment Break
3:30
Navigating the Essentials in Pre-Launch Market Insights
Stephen Murdock
Principal
CharlesView Solutions, LLC
4:30
Close of Day One
Networking, Wine and Cheese Reception immediately following the final session on day one
Day Two | Tuesday, September 12, 2017
7:30
Continental Breakfast
8:00
Chairman’s Review of Day One
Sasha Zbitnoff
Associate Director, Commercial Project Management
Alkermes, Inc.
Keys to Commercialization,
Marketing and Post-Launch Success
8:15
Preparing for a Global Launch — Defining a Path for New Products
Lori Peters
Senior Principal
Qpharma
9:00
The Ever-Changing Dynamics of Launch Pricing
Mike Rizzo
Principal
ClearView Healthcare Partners
9:45
Networking and Refreshment Break
10:15
New Product Pricing and Communications
Jill Charbonneau
Director Regulatory Advertising Promotions, Product Launch & Strategy
Marathon Pharmaceuticals
11:00
Optimizing the Material Review Process in the Digital Explosion Age
Jennifer Guenther
Vice President, Commercial Excellence
HighPoint Solutions
11:45
Developing a Winning Product Strategy for Launch
Ted Hoffman
Senior Director, Launch Management
Teva Pharmaceuticals
12:30
Networking Luncheon
WORKSHOP
1:30
Payer Negotiation Simulation
Incumbent Product
New Product
Payer Perspective
Workshop participants are divided into one of the three groups outlined above. The existing and new product teams develop and present formulary/rebate proposals for the payer to evaluate. Representatives from each team negotiates with the payer group. The financial implications from the manufacturer and payer’s perspective are assessed along with qualitative factors. The payer group develops and communicates their offer based on the negotiations with the teams. A panel determines which team got the most favorable outcome from the payer negotiations.
WORKSHOP LEADER:
Murray Kay
Former CFO, Solvay Pharmaceuticals &
Former Commercial Controller Specialty Products
AbbVie
3:00
Close of Conference
